Transfemoral Management of Mechanical Aortic Valve Failure via Disk Fragmentation

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  European Heart Journal https://doi.org/10.1093/eurheartj/ehag019 
Dr. Ignacio J Amat-Santos  et al.

Points

Researchers developed a novel minimally invasive technique called ViMech that allows for the treatment of defective mechanical aortic valves using a catheter based approach rather than repeat open heart surgery.
The procedure involve using specialized catheter tools to intentionally fragment and safely retrieve the mobile disks of a failing mechanical valve while protecting the bloodstream from potential debris and fragments.
In a first in human study involving three high risk patients aged sixty seven to seventy nine the technique successfully restored normal blood flow with rapid recovery times recorded.
All treated patients remained alive and asymptomatic at a six month follow up with no major neurological or vascular events and stable function of the newly implanted transcatheter heart valves.
This innovative strategy may transform clinical management by providing a less aggressive therapeutic option for thousands of fragile patients and potentially reducing the need for lifelong anticoagulation therapy regimens.

Summary

This research evaluated the technical feasibility and clinical translation of the mechanical valve-in-valve (ViMech) procedure, a novel minimally invasive strategy for treating dysfunctional mechanical aortic valves. While transcatheter aortic valve implantation (TAVI) is established for bioprosthetic failure, mechanical valve dysfunction previously mandated high-risk repeat open-heart surgery. The ViMech approach utilizes catheter-based tools to intentionally fragment and retrieve the mobile disks of a defective mechanical prosthesis, followed by the percutaneous implantation of a transcatheter heart valve to restore hemodynamic function.

The clinical application was documented in a first-in-human study involving three patients aged 67 to 79 years who presented with severe mechanical valve failure and prohibitive surgical risk. The procedures were performed via transfemoral access without the need for sternotomy. The strategy successfully achieved controlled disk removal and valve deployment in 100% of the cases. At the six-month follow-up, 100% of the patients remained alive and asymptomatic, with echocardiography confirming stable transcatheter prosthesis function and no major neurological or vascular complications reported.

These results suggest that the ViMech technique is a viable therapeutic alternative for a patient population that previously lacked realistic treatment options. Beyond procedural success, the technique allowed for a simplified antithrombotic regimen in some cases, potentially eliminating the lifelong anticoagulation required for mechanical valves. While limited by a small sample size, this translational work demonstrates that percutaneous disk disruption and retrieval can be performed safely, shifting the management paradigm for complex mechanical valve failure from high-risk reoperation toward less invasive interventional cardiology.

Link to the article: https://academic.oup.com/eurheartj/advance-article-abstract/doi/10.1093/eurheartj/ehag019/8445364?redirectedFrom=fulltext&login=false#google_vignette

References

Amat-Santos, I. J., Real, C., Galán-Arriola, C., Diz-Díaz, J., Párraga, R., Pérez-Camargo, D., Stepanenko, A., Lujan-Rodríguez, F., Rodriguez, B., González-Calvo, E., García-Gómez, M., Filgueiras-Rama, D., Pereda, D., Fernández-Jiménez, R., García-Álvarez, A., Jain, A., Pensotti, F., San Román, J. A., & Ibanez, B. (2026). Transcatheter aortic valve-in-mechanical valve replacement: A first-in-human study. European Heart Journal, ehag019. https://doi.org/10.1093/eurheartj/ehag019